Fangming Lin, MD, PhD
Appointments
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Credentials & Experience
Board Certifications
- Pediatrics
- Pediatric Nephrology
Clinical Expertise
- Proteinuria
- Peritoneal Dialysis
- Nephrotic Syndrome
- Kidney Transplantation
- Kidney Stones
- Hypertension
- Hemolytic Uremic Syndrome
- Hemodialysis
- Hematuria
- Glomerulonephritis
Specialties
Education & Training
- Fujian Medical University (China)
- Internship: New York University Medical Center
- Residency: New York University Medical Center
- Fellowship: Seattle Children's Hospital
About Fangming Lin
Dr. Fangming Lin joined CUMC in June 2011 as the Division Director of Pediatric Nephrology after 10 years of serving University of Texas Southwestern Medical Center at Dallas. She received her MD degree from Fujian Medical University in China and her PhD degree in Pharmacology at New York Medical College. Dr. Lin underwent pediatric residency training at New York University Medical Center and pediatric nephrology fellowship training at Seattle Children’s Hospital of the University of Washington.
As a physician scientist, Dr. Lin has a strong interest in both patient care and science and discovery. She is passionate and experienced in treating children with congenital kidney conditions as well as acquired kidney diseases. Her laboratory research focuses on the understanding and better treatment for acute and chronic kidney disease. She is the first recipient of the Norman Siegel Pediatric Research Grant Award jointly issued by the American Society of Nephrology (ASN) and the American Society of Pediatric Nephrology (ASPN) in 2006 - a humbling selection of which she is proud. Dr. Lin has also served on several committees at the national and international levels.
Email: fl2300@cumc.columbia.edu
Academic Titles
- Associate Professor of Pediatrics
Administrative Positions
- Chief, Division of Pediatric Nephrology
Hospital Affiliations
- NewYork-Presbyterian/Columbia
- NewYork-Presbyterian/Morgan Stanley Children's Hospital
Gender
- Female
Insurance Accepted
Aetna
- EPO
- HMO
- Medicare Managed Care
- NY Signature
- NYP Employee Plan
- POS
- PPO
- Signature Administrators
- Student Health
Affinity
- Essential Plan
- Medicaid Managed Care
Amida Care
- Special Needs Plan
Cigna
- EPO
- Great West
- HMO
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicaid Managed Care
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield
- EPO
- Medicare Managed Care
- PPO
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
- Medicaid Managed Care
Fidelis Care
- Child/Family Health Plus
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Medicare Managed Care
Local 1199
- Local 1199
MagnaCare
- MagnaCare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Oxford Health Plans
- Freedom
- Liberty
UnitedHealthcare
- Columbia University Employee Plan
- Compass (Exchange)
- HMO
- Medicaid (Community Plan)
- Medicare Managed Care
- POS
- PPO
VNSNY CHOICE
- Medicare Managed Care
- SelectHealth
- Special Needs Plan
WellCare
- Medicaid Managed Care
- Medicare Managed Care
*Please contact the provider’s office directly to verify that your particular insurance is accepted.
Contact & Locations
Suite (Central)
New York, New York 10032
Research
Our laboratory studies kidney injury and repair using a variety of mouse models. We are currently focusing on the function and molecular regulation of epithelial autophagy. We have shown that following urinary tract obstruction or ischemic injury to the kidney, autophagy is activated in a regulated and dynamic fashion for renal tubular survival and repair. A stress-responsive transcription factor FoxO3 plays an important role in regulating the stress response during the acute injury and the progression to chronic kidney disease. Our goal is to use the knowledge learned from animal studies to help design methods that integrate modulation of autophagy into prevention and treatment for human kidney disease.
Grants
GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKI AND CKD IN HUMANS BORN PRETERM (Federal Gov)
Feb 15 2019 - November 30 2022
GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKIAND CKD IN HUMANS BORN PRETERM (Federal Gov)
Feb 15 2019 - Nov 30 2022
PSDP FELLOWSHIP (Federal Gov)
Jul 1 2019 - Jun 30 2020
ROLE OF AUTOPHAGY IN MALADAPTIVE RENAL REPAIR FOLLOWING ACUTE KIDNEY INJURY (Federal Gov)
Sep 21 2016 - Aug 31 2019
PSDP FELLOWSHIP (Federal Gov)
Jul 1 2018 - Jun 30 2019
ADVANCING CLINICAL RESEARCH IN PRIMARY GLOMERULAR DISEASES (Federal Gov)
Sep 16 2013 - May 31 2019
STEM CELL THERAPY FOR ACUTE KIDNEY INJURY (Federal Gov)
Jun 1 2011 - Jul 31 2015
ROLE OF AUTOPHAGY IN KIDNEY TUBULAR ATROPHY (Private)
Jun 1 2011 - May 31 2014
For a complete list of publications, please visit PubMed.gov